Search results

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.

Shielding is one of the government interventions aimed at reducing mortality from COVID-19. Those considered at highest clinical risk of mortality and severe morbidity from COVID-19 (defined as Clinically Extremely Vulnerable) were identified to be on the Shielded Patient List (SPL).

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.